London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950

Our Clients

Order Informer

Home > News >

DSM commences tender offer for Kensey Nash

May 22/2012

(Reuters) --  Royal DSM, the global Life Sciences and Materials Sciences company, announced that its indirect wholly-owned subsidiary, Biomedical Acquisition Corporation, has commenced its previously announced tender offer for all outstanding shares of common stock of Kensey Nash. 

The Kensey Nash board of directors has unanimously determined that, among other things, the offer is fair to and in the best interests of Kensey Nash's stockholders and unanimously recommends that Kensey Nash's stockholders accept the offer and tender their shares.

The tender offer is scheduled to expire at 12:00 midnight at the end of Monday, 18 June 2012, unless the offer is extended.

Complete terms and conditions of the tender offer are set forth in the Offer to Purchase, Letter of Transmittal and other related materials that will be filed by DSM and Biomedical Acquisition Corporation on 21 May 2012. 

Kensey Nash is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopedic, sports medicine, spine, trauma, craniomaxillofacial and general surgery markets.
Author:Anna Larionova
Tags:Medicine, DSM.
Category:General News
| More

Leave a comment

MRC help


 All News   News subscribe